SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-091368
Filing Date
2017-03-22
Accepted
2017-03-22 06:11:33
Documents
4
Period of Report
2017-03-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d326337d8k.htm 8-K 19070
2 EX-1.1 d326337dex11.htm EX-1.1 146324
3 EX-5.1 d326337dex51.htm EX-5.1 7902
4 GRAPHIC g326337g0322070408861.jpg GRAPHIC 2581
  Complete submission text file 0001193125-17-091368.txt   178112
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 17705641
SIC: 2834 Pharmaceutical Preparations